Microbiome recovery in adult females with uncomplicated urinary tract infections in a randomised phase 2A trial of the novel antibiotic gepotidacin (GSK140944)/Experiment 3

From BugSigDB


Reviewed Marked as Reviewed by Folakunmi on 2023-12-12

Curated date: 2023/11/14

Curator: Chinelsy

Revision editor(s): Chinelsy, Folakunmi, Victoria

Subjects

Location of subjects
United States of America
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Urinary tract infection INFECTION, URINARY TRACT,TRACT, INFECTION OF URINARY,urinary tract infection,urinary tract infection (disease),Urinary tract infection
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Day 1 (pre-dose)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Day 5 (end of dosing or post-dose)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
This represented the condition at the end of the 5-day regimen of gepotidacin treatment in the pharyngeal cavity microbiome.
Group 0 sample size Number of subjects in the control (unexposed) group
22
Group 1 sample size Number of subjects in the case (exposed) group
22

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
raw counts
Statistical test
DESeq2
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.01
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Chao1 Abundance-based estimator of species richness
decreased

Signature 1

Reviewed Marked as Reviewed by Folakunmi on 2023-12-12

Curated date: 2023/11/14

Curator: Chinelsy

Revision editor(s): Chinelsy, Folakunmi

Source: within results text under "changes in detected abundances in bacterial genera", paragraph 2, Figure 3

Description: Relative abundances of assigned bacterial taxa.

Abundance in Group 1: increased abundance in Day 5 (end of dosing or post-dose)

NCBI Quality ControlLinks
Acidaminococcus
Aerococcus
Faecalibacterium
Megasphaera
Ruminococcus
Shuttleworthella
Lactobacillus
Faecalibacterium sp. UBA1819
uncultured Oscillospiraceae bacterium
Bacteroides
Campylobacter

Revision editor(s): Chinelsy, Folakunmi

Signature 2

Reviewed Marked as Reviewed by Folakunmi on 2023-12-12

Curated date: 2023/11/14

Curator: Chinelsy

Revision editor(s): Chinelsy, Folakunmi

Source: within results text under "changes in detected abundances in bacterial genera", paragraph 2, Figure 3

Description: Relative abundances of assigned bacterial taxa.

Abundance in Group 1: decreased abundance in Day 5 (end of dosing or post-dose)

NCBI Quality ControlLinks
Actinobacillus
Aggregatibacter
Alloprevotella
Bacteroides
Campylobacter
Capnocytophaga
Catonella
Dialister
Finegoldia
Fusobacterium
Granulicatella
Lachnoanaerobaculum
Lactobacillus
Lawsonella
Leptotrichia
Neisseria
Parabacteroides
Porphyromonas
Prevotella
Ruminiclostridium
Selenomonas
Stomatobaculum
Streptococcus
Tannerella
Veillonella
[Ruminococcus] torques

Revision editor(s): Chinelsy, Folakunmi